Dear Mr Tan, I strongly suspect that (name removed) is performing an unethnical forex magic trick to lure gullible students to sign up for his forex courses. Please see one of his video (link removed). He probably have an accomplice behind the scene to feed him the calls for long or short. His accomplice may be somewhere else having access to the chart on the screen and signal long or short call by simply calling his handphone. One on his left pocket and the other on his right pocket. I am a forex trader myself and i am very sure this is a scam. Please help to unweed this unscrupulous forex school before more gullible students fall into the trap.
The rules of Universal Studio Singapore said that "for same day admission, you must present the Studio admission ticket and hand stamp for re-entry".
I recall visiting the theme parks in America where they recognize the hand stamp (or similar tags). They do not require the admission ticket to be shown as well. I wonder if this reflects the peculiar requirements in Singapore - where it is usual to add to the hassle for customers?
Researchers Report Some Success Against Advanced Lung Cancer With Epigenetic Drugs
Nov. 9, 2011? -- A new approach to treating cancer appears to help certain patients with advanced lung cancer, and researchers say they think they may have a way of spotting those who will benefit.
The small study is generating big excitement in the world of cancer treatment because it demonstrates that so-called epigenetic drugs may work when traditional chemotherapy has failed.
Epigenetic drugs work by controlling gene expression -- the way information from genes is used to create products such as proteins.
The study is published in Cancer Discovery.
"This is a ... groundbreaking study, showing that by modifying the epigenetics of a cancer cell we can get real responses in lung cancer," said Jeffrey A. Engleman, MD, PhD, director of thoracic oncology at Massachusetts General Hospital, in Boston, in a news briefing. "And getting real responses in lung cancer is actually quite difficult, so we take special notice of therapies that can do this." He was not involved in the research.
New Approach to Treating Cancer
All 45 patients recruited for the study had non-small-cell lung cancer, the leading cancer killer in the U.S.
All had tumors that had spread beyond their lungs despite treatment with an average of three other therapies.
"These are patients with very advanced disease" who have little chance of survival, says study researcher Charles Rudin, MD, PhD. He is professor of oncology and associate director for clinical research at Johns Hopkins University Kimmel Cancer Center in Baltimore.
Rudin says that he has consulted for Syndax Pharmaceuticals, the company that makes one of the drugs tested in the study.
Most patients with cancer this advanced are only expected to survive for about four months, the researchers note.
After treatment with a combination of the medications Vidaza, which is FDA approved to treat certain rare blood disorders, and the experimental pill entinostat, however, the average survival for the entire group was 6.4 months.
Doctors who wrote an editorial on the study note that this result was just shy of the same average survival (6.7 months) seen in patients treated with Tarceva, the only medication that's approved to treat patients with non-small-cell lung cancer that has spread to other organs.
The figure from the new study, however, included 11 patients who dropped out of the study before finishing a single cycle of treatment.
Among patients who finished at least one full treatment cycle, the average survival was even higher, about 8.6 months.
What's more, four of 19 patients who got chemotherapy after the experimental drug combo had dramatic responses to those treatments, "raising the hypothesis that maybe the epigenetic therapy is in some way priming the tumor for response to chemotherapy," Rudin says.
In total, seven patients who took part in the trial are still alive; two have survived for more than four years.
An American told me that 30 years ago, the banks will give a mortgage to the borrower to buy a house for not more 3 years of the income of the breadwinner (and the income of the working spouse is disregarded). The bank also required the borrower to make a down-payment of 10% for the house.
If this rule is applied in Singapore today, the average price of a 4 room HDB flat should be $120,000 (assuming an average income of the breadwinner to be $40,000).
The price of HDB flat that is being charged is about 3 times of this benchmark - and a 4 room HDB flat is considered to be quite modest, compared to a typical house with a land in America. (See http://en.wikipedia.org/wiki/Public_housing_in_Singapore)
This shows how costly are HDB flats in Singapore - and they are considered as "public housing". No wonder, both parents have to work and they still do not have enough money for retirement. The housing is far too expensive.
There is a vacancy for a person to carry out office administrative work at our office at Midview City, Sin Ming Lane. The working hours are from 9 am to 6 pm, five days a week. The expected salary is $1,500 per month. Preference will be given to a candidate who has working experience and who lives nearby. Interested parties are required to send in a resume and expected salary to ceo@tankinlian.com. The candidate is expected to start work during the third week of November 2011.
The candidate must be a citizen or permanent resident or someone who has a dependent work pass. Candidates who wish to work part time on a reduced salary will also be considered.
My views It is better for Singapore investors to keep their accounts with local brokerages, rather than foreign brokerages, due to this type of problem. The local brokerages are more likely to keep their money in Singapore. Even though the client's monies are kept outside Singapore, I believe that they belong to the clients and should be returned to the liquidators on demand. I don' think that the foreign banks or other institutions have the right to reject the request of the liquidators to return the monies. But, it seems that international finance is getting very complicated and risky.
